HCPLive Network
Latest Oncology Headlines
By Tony Berberabe, MPH
Epizyme, a Cambridge, Massachusetts-based biotech, opted for independence, with a successful IPO in 2013.
Physicians who use Windows XP in their practices may be affected by Microsoft's recent discontinuation of support for the program, according to an article published April 8 in Medical Economics.
Six percent of patients with colorectal cancer have interval cancers, which develop within six to 60 months of colonoscopy, according to a study published in the April issue of Gastroenterology.
By By Lary A. Robinson, MD
Every patient with a pancoast tumor of the lung should be evaluated by a Pancoast-experienced thoracic surgeon (and neurosurgeon) before ruling out surgery, and before starting induction therapy.
Many Americans are paying less for prescription drugs, but some are having to deal with sharp rises in the cost of specialty medicines for rare or serious diseases, according to a new report.
By Anna Azvolinsky, PhD
Lymphoma expert Andre Goy, MD, provides insight into the rapidly changing treatment landscape for patients with mantle cell lymphoma.
The use of neoadjuvant and adjuvant chemotherapy for the treatment of muscle-invasive bladder cancer is associated with a survival benefit in the general population, according to research published online April 14 in Cancer.
By Andrew J. Roth
Patients with localized prostate cancer at intermediate or high risk for progression experience better outcomes when 6 months of androgen deprivation therapy is added to standard radiotherapy.
Cytomegalovirus may contribute to anemia in patients with chronic kidney disease, according to a study published online April 10 in the Journal of the American Society of Nephrology.
With the resignation of US Health and Human Services Secretary Kathleen Sebelius on Friday, the Affordable Care Act will get a fresh face. But turning around public perception of the controversial health care reform law in a politically charged mid-term election year poses an enormous challenge for the department's next leader, policy experts said.
The future of privately owed oncology practices in the nation’s cancer care system is growing increasingly fragile amid mounting financial pressures, even as more new patients are seeking help.
High intake of saturated fats is associated with increased risk of certain subtypes of breast cancer, according to research published online April 9 in the Journal of the National Cancer Institute.
Despite an overall improved mortality seen during the past 10 years, advancing age is associated with higher morbidity and mortality in colorectal cancer resection, according to a study published online April 9 in JAMA Surgery.
By Silas Inman
A novel 100-locus DNA signature obtained from pretreatment biopsies accurately classified 75% of patients with untreated prostate cancer as low- or high-risk.
Exposure to video-based education increases men's skin awareness and attendance at whole-body clinical skin examinations, according to a study published in the April issue of JAMA Dermatology.
Autologous nasal cartilage tissues can be engineered and clinically used for functional restoration of alar lobules after tumor resection, according to a study published online April 11 in The Lancet.
By Silas Inman
The recent approval of pertuzumab as part of a combination neoadjuvant treatment for patients with early-stage breast cancer has paved the way for wider use of the regimen in preoperative settings.
By Andrew L. Pecora, MD
I would like to begin by expressing my excitement about my new position as editor-in-chief of Oncology Business Management.
By Andrew J. Roth
An updated guideline from ASCO regarding the use of sentinel lymph node (SLN) biopsy in early stage breast cancer supports the use of the procedure over axillary lymph node dissection (ALND) in a larger group of patients than previously recommended.
By Jodie Barr, DO
I can remember waiting anxiously on match day; checking the computer every few seconds to see if I matched.
Physician's Money Digest
Attitudes toward investments are very strongly correlated to how they are performing at the time. Gold was preferred in 2011 and real estate in 2002. So what do investors like best today?
Master Limited Partnerships are distributing income of almost 7% per year to investors at a time when short-term bonds are paying close to zero, which makes them an enticing option for retirees.
$AD300x250BB$